These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38644092)

  • 1. The effectiveness of autologous platelet concentrates in prevention and treatment of medication-related osteonecrosis of the jaws: A systematic review.
    Nowak SM; Sacco R; Mitchell FL; Patel V; Gurzawska-Comis K
    J Craniomaxillofac Surg; 2024 Jun; 52(6):671-691. PubMed ID: 38644092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review.
    Fortunato L; Bennardo F; Buffone C; Giudice A
    J Craniomaxillofac Surg; 2020 Mar; 48(3):268-285. PubMed ID: 32063481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication-related osteonecrosis of the jaw: Is autologous platelet concentrate application effective for prevention and treatment? A systematic review.
    Lopez-Jornet P; Sanchez Perez A; Amaral Mendes R; Tobias A
    J Craniomaxillofac Surg; 2016 Aug; 44(8):1067-72. PubMed ID: 27318752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser Devices and Autologous Platelet Concentrates in Prevention and Treatment of Medication-Related Osteonecrosis of the Jaws: A Systematic Review.
    Scribante A; Ghizzoni M; Pellegrini M; Pulicari F; Spadari F
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241204
    [No Abstract]   [Full Text] [Related]  

  • 5. Autologous platelet concentrates in treatment of medication related osteonecrosis of the jaw.
    Rusilas H; Balčiūnaitė A; Žilinskas J
    Stomatologija; 2020; 22(1):23-27. PubMed ID: 32706343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for managing medication-related osteonecrosis of the jaw.
    Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O; Peter JU
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012432. PubMed ID: 35866376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature.
    Del Fabbro M; Gallesio G; Mozzati M
    Eur J Cancer; 2015 Jan; 51(1):62-74. PubMed ID: 25466505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for managing medication-related osteonecrosis of the jaw.
    Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of complementary treatment with autologous platelet concentrates and/or mesenchymal stem cells in chemical osteonecrosis of the jaw. Systematic review of the literature.
    Escobedo MF; Junquera S; Gonzalez C; Vasatyuk S; Gallego L; Barbeito E; Junquera LM
    J Stomatol Oral Maxillofac Surg; 2022 Feb; 123(1):51-58. PubMed ID: 33609789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Autologous Platelet Concentrates in the Treatment of Medication-Related Osteonecrosis of the Jaw.
    Ye P; Wei T; Lu ZY; Cai YJ
    J Craniofac Surg; 2021 Mar-Apr 01; 32(2):621-625. PubMed ID: 33704995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of fibrin-rich platelets and leukocytes (L-PRF) in tissue repair in surgical oral procedures in patients using zoledronic acid-case-control study.
    Parise GK; Costa BN; Nogueira ML; Sassi LM; Schussel JL
    Oral Maxillofac Surg; 2023 Sep; 27(3):507-512. PubMed ID: 35739366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and management of drug-induced osteonecrosis of the jaws using platelet-rich fibrin: A clinical feasibility study.
    Alrmali A; Saleh MHA; Kurdi SMS; Sabri H; Meghil MM; Wang HL
    Clin Exp Dent Res; 2023 Oct; 9(5):791-798. PubMed ID: 37605488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation.
    Inchingolo F; Cantore S; Dipalma G; Georgakopoulos I; Almasri M; Gheno E; Motta A; Marrelli M; Farronato D; Ballini A; Marzullo A
    J Biol Regul Homeost Agents; 2017; 31(3):811-816. PubMed ID: 28958140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promising results of surgical management of advanced medication related osteonecrosis of the jaws using adjunctive leukocyte and platelet rich fibrin.
    Özalp Ö; Yıldırımyan N; Öztürk C; Kocabalkan B; Şimşek Kaya G; Sindel A; Altay MA
    BMC Oral Health; 2021 Dec; 21(1):613. PubMed ID: 34852823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Leucocyte-rich and platelet-rich fibrin (L-PRF) in the treatment of the medication-related osteonecrosis of the jaws (MRONJ).
    Cano-Durán JA; Peña-Cardelles JF; Ortega-Concepción D; Paredes-Rodríguez VM; García-Riart M; López-Quiles J
    J Clin Exp Dent; 2017 Aug; 9(8):e1051-e1059. PubMed ID: 28936298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous Platelet Concentrates (APCs) for Hard Tissue Regeneration in Oral Implantology, Sinus Floor Elevation, Peri-Implantitis, Socket Preservation, and Medication-Related Osteonecrosis of the Jaw (MRONJ): A Literature Review.
    Mijiritsky E; Assaf HD; Kolerman R; Mangani L; Ivanova V; Zlatev S
    Biology (Basel); 2022 Aug; 11(9):. PubMed ID: 36138733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of treatments for medication-related osteonecrosis of the jaw: A systematic review and meta-analysis.
    El-Rabbany M; Sgro A; Lam DK; Shah PS; Azarpazhooh A
    J Am Dent Assoc; 2017 Aug; 148(8):584-594.e2. PubMed ID: 28527518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ).
    Miranda M; Gianfreda F; Raffone C; Antonacci D; Pistilli V; Bollero P
    Biomed Res Int; 2021; 2021():4948139. PubMed ID: 34095295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of laser-assisted treatments for medication-related osteonecrosis of the jaw: a systematic review.
    Li FL; Wu CB; Sun HJ; Zhou Q
    Br J Oral Maxillofac Surg; 2020 Apr; 58(3):256-267. PubMed ID: 31926767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.